Transactions

Peterson & Co. acts for Revive Therapeutics Ltd. in Rights Offering

On May 16, 2016, Revive Therapeutics Ltd. (TSXV:  RVV) announced a best efforts rights offering to raise $2.2 million.  Revive is focused on commercializing treatments for gout, and rare diseases such as cystinuria, Wilson’s disease and Rett syndrome.

Back

Recent Transactions

31 May 2022

Peterson McVicar Acts for Red Cloud Securities Inc. in Brokered Private Placement with Reyna Silver Corp. for up to C$3.0 Million

Learn More

30 May 2022

Peterson McVicar Acts for Probe Metals in Private Placement

Learn More

06 May 2022

Peterson McVicar Acts for Galway Metals in Upsizing of $8 Million Bought Deal Private Placement Financing to $10 Million

Learn More

05 May 2022

Peterson McVicar Acts for Galway Metals in $8 Million Bought Deal Private Placement Financing

Learn More